Minimum Shelf Life Requirements. Each Party shall use commercially reasonable efforts to supply its Compound hereunder with an adequate remaining shelf life at the time of Delivery to meet the Study requirements.
Minimum Shelf Life Requirements. Each Party shall supply its Compound hereunder with an adequate remaining shelf life at the time of Delivery to meet the Study requirements. The shelf life for each Compound to continue to be conforming and meet Specifications shall at a minimum be [***] from the time of Delivery; provided, that the Compound is handled and stored according to the specified handling and storage conditions.
Minimum Shelf Life Requirements. Merck shall use commercially reasonable efforts to supply its Compound hereunder with an adequate remaining shelf life at the time of Delivery to meet the Study requirements. Adaptimmune shall supply its Compound in accordance with the Protocol and as required to meet patient demand at Study sites.
Minimum Shelf Life Requirements. COMPANY shall use all reasonable efforts to supply the COMPANY Compound hereunder with at least twelve (12) months remaining shelf life at the time of Delivery.
Minimum Shelf Life Requirements. Each Party shall provide the other Party with its Compound with shelf life as set forth in the Clinical Quality Agreement.
Minimum Shelf Life Requirements. Each Party shall use commercially reasonable efforts to supply its Compound hereunder with an adequate remaining shelf life at the time of Delivery to meet the requirements of the Collaboration Program. Certain portions of this document have been marked “[C.I.]” to indicate that confidential treatment has been requested for such confidential information. The confidential portions have been omitted and submitted separately with the Securities and Exchange Commission.
Minimum Shelf Life Requirements. Each Party shall use commercially reasonable efforts to supply its Compound or Compounds hereunder with an adequate remaining shelf life at the time of Delivery to meet the Study requirements. [***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.
Minimum Shelf Life Requirements. Each Party shall use commercially reasonable efforts to supply the MSD Compound (in the case of MSD) hereunder with an adequate remaining shelf life at the time of Delivery to meet the Study requirements. 8.4. Provision of the MSD Compound and the Novocure Device. 8.4.1. MSD will deliver the MSD Compound DAP (INCOTERMS 2020) to Novocure’s, or its designee’s, location as specified by Novocure (“Delivery” with respect to such MSD Compound). [***] 8.4.2. Novocure is solely responsible, at its own cost, for supplying and providing access to the Novocure Device for use in the Study. Novocure shall ensure that all such activities are conducted in compliance with cGMP, GCP and other Applicable Law and the Clinical Quality Agreement (if applicable). 8.5. Labeling and Packaging; Use, Handling and Storage. 8.5.1. The Parties’ obligations with respect to the labeling and packaging of the MSD Compound are as set forth in the Clinical Quality Agreement. Notwithstanding the foregoing or anything to the contrary contained herein, MSD shall provide the MSD Compound to Novocure in the form of [***]. 8.5.2. Novocure shall: (a) use the MSD Compound solely for purposes of performing the Study; (b) not use the MSD Compound in any manner that is inconsistent with this Agreement or for any commercial purpose; and (c) label, use, store, transport, handle and dispose of the MSD Compound in compliance with Applicable Law and the Clinical Quality Agreement, as well as all instructions of MSD. Novocure shall not reverse engineer, reverse compile, disassemble or otherwise attempt to derive the composition or underlying information, structure or ideas of the MSD Compound, and in particular shall not analyze the MSD Compound by physical, chemical or biochemical means except as necessary to perform its obligations under the Clinical Quality Agreement. 8.6.
Minimum Shelf Life Requirements. Each Party shall use commercially-reasonable efforts to supply its Compound hereunder with an adequate remaining shelf life at the time of Delivery to meet the MSD Compound Study requirements. [***] = Certain confidential information contained in this document, marked by brackets, is omitted because it is not material and would be competitively harmful if publicly disclosed.
Minimum Shelf Life Requirements. Ideaya will use Commercially Reasonable Efforts to supply the Ideaya Compound hereunder with adequate shelf life remaining at the time of Delivery, provided, that Ideaya will use Commercially Reasonable Efforts to supply the Ideaya Compound with no less than [***] months remaining shelf life. If Ideaya Compound is only available with less than [***] months remaining shelf life, Ideaya will promptly notify Amgen and both Parties will work in good faith to meet the requirements of the Study.
